Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2642301000168112 | Acamprosate (Apotex) (acamprosate calcium 333 mg) enteric tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2642311000168110 | Acamprosate (Apotex) 333 mg enteric tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acamprosate (Apotex) 333 mg enteric tablet | Is a | Acamprosate (Apotex) | true | Inferred relationship | Some | ||
| Acamprosate (Apotex) 333 mg enteric tablet | Is a | acamprosate calcium 333 mg enteric tablet | true | Inferred relationship | Some | ||
| Acamprosate (Apotex) 333 mg enteric tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Acamprosate (Apotex) 333 mg enteric tablet | has manufactured dose form | enteric tablet | true | Inferred relationship | Some | ||
| Acamprosate (Apotex) 333 mg enteric tablet | has unit of use | tablet | true | Inferred relationship | Some | 1202466245 | |
| Acamprosate (Apotex) 333 mg enteric tablet | has Australian BoSS | acamprosate calcium | true | Inferred relationship | Some | 1202466244 | |
| Acamprosate (Apotex) 333 mg enteric tablet | has intended active ingredient | acamprosate | true | Inferred relationship | Some | 1202466244 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acamprosate (Apotex) 333 mg enteric tablet, 180, blister pack | has TPUU | True | Acamprosate (Apotex) 333 mg enteric tablet | Inferred relationship | Some | 1 |
| Acamprosate (Apotex) 333 mg enteric tablet, 180 | has TPUU | True | Acamprosate (Apotex) 333 mg enteric tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR